openPR Logo
Press release

Human Papillomavirus Vaccine Market Trends, Business Overview, Industry Growth and Forecast to 2031

11-27-2024 09:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Human Papillomavirus Vaccine Market

Human Papillomavirus Vaccine Market

The global human papillomavirus vaccine market is anticipated to grow at a significant CAGR of 7.1% during the forecast period 2024-2031. The major drivers attributed to the growth of the market are rising awareness among people regarding the human papillomavirus vaccine. With the rise in the cases of cervical cancer every year, the HPV vaccination is increasing, which is aiding in the growth of the market. Additionally, the government initiatives and programs to provide vaccines to people are supporting in combating the disease.

Get Free Sample link @ https://www.omrglobal.com/request-sample/human-papillomavirus-vaccine-hpv-market

Moreover, the major players in the market are going for mergers and acquisitions for new product launches to further contribute to the market growth. For instance, in June 2020, on the eve of the Global Vaccine Summit 2020, vaccine manufacturers Merck & Co. inc., GlaxoSmithKline PLC, Innovax Pharmaceutical Ltd., and Serum Institute of India Pvt. Ltd., ramped up human papillomavirus vaccine (HPV) supply availability for Gavi-supported countries, which have amongst the highest cervical cancer burdens globally.

Full report of Human Papillomavirus Vaccine Market available @ https://www.omrglobal.com/industry-reports/human-papillomavirus-vaccine-hpv-market

Market Coverage

Segment Covered-

By Type
By Indication
Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape - including,., Merck & Co. inc., GlaxoSmithKline PLC, Innovax Pharmaceutical Ltd., Serum Institute of India Pvt. Ltd., AstraZeneca PLC, and Johnson & Johnson Services, Inc., among others

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Human Papillomavirus Vaccine Market Report Segment

By Type

Bivalent
Quadrivalent
Nonavalent

By Indication

Cervical Cancer
Anal Cancer
P Cancer
Vaginal Cancer
Oropharyngeal Cancer
Genital Warts
Others


Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/human-papillomavirus-vaccine-hpv-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Papillomavirus Vaccine Market Trends, Business Overview, Industry Growth and Forecast to 2031 here

News-ID: 3758675 • Views:

More Releases from Orion Market Research

Anti-Acne Cosmetics Market Size, Share, Growth Insight, and Future Forecast - 2031
Anti-Acne Cosmetics Market Size, Share, Growth Insight, and Future Forecast - 20 …
The global anti-acne cosmetics market is estimated to grow at a CAGR of nearly 8.0% during the forecast period. Rising demand for cosmetics among men and women are supporting to drive market growth. There is a considerable rise in the adoption of cosmetic products owing to the increasing concerns related to skin problems and self-consciousness about appearance. The major players operating in the cosmetics segment include L'Oréal SA, Unilever PLC,
Resection Guides Market Demand Analysis, Type, Statistics, Regions and Forecast - 2031
Resection Guides Market Demand Analysis, Type, Statistics, Regions and Forecast …
The global resection guides market is anticipated to grow at a significant CAGR 5.3% during the forecast period (2024-2031). Resection is the medical term used for surgically removing a part or all of a tissue, structure or organ and is performed for a wide variety of reasons. It may remove a tissue that is cancerous or diseased. The surgery may treat or cure a disease process. The major factor driving
Levofloxacin Market Business overview, Upcoming Trends and Top Company Analysis Forecast - 2031
Levofloxacin Market Business overview, Upcoming Trends and Top Company Analysis …
The global levofloxacin market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2024-2031). A major element driving market expansion is hospital-acquired infection (HAI). Pneumonia, bloodstream infection, surgical site infection, and urinary tract infection are among the most frequent hospital-acquired infections. Government regulations to prevent and control hospital infections, the need for disinfectants and disposable safety goods to reduce the danger of infectious microorganisms will
Lixisenatide Market Industry Share, Size: 2024 with Growth, Segments and Forecast - 2031
Lixisenatide Market Industry Share, Size: 2024 with Growth, Segments and Forecas …
The global lixisenatide market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in June 2021, Novo Nordisk received US Food and Drug Administration (FDA) approval of Wegovy (semaglutide)

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the